• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 CD138 磁珠阳性选择对骨髓浆细胞表面标志物的影响。

Impact of CD138 Magnetic Bead-based Positive Selection on Bone Marrow Plasma Cell Surface Markers.

机构信息

Division of Hematology, Mayo Clinic, Rochester, MN.

Division of Hematology, Mayo Clinic, Rochester, MN.

出版信息

Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e48-e51. doi: 10.1016/j.clml.2020.08.003. Epub 2020 Aug 5.

DOI:10.1016/j.clml.2020.08.003
PMID:32873534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7854838/
Abstract

BACKGROUND

Isolation of malignant plasma cells from bone marrow of patients with monoclonal gammopathies is critical for studies into the disease biology. The plasma cells are typically isolated by positive selection using plasma cell markers such as CD138. Here we have examined the effect of CD138 magnetic bead selection on the expression of other surface phenotypic markers on plasma cells.

MATERIALS AND METHODS

Bone marrow aspirates from 16 patients were split and prepared using 2 methods before staining for flow cytometric evaluation. The first method (whole bone marrow) used an ammonium-chloride-potassium lyse of whole bone marrow followed by 2 phosphate buffered saline washes. The second method used CD138-positive magnetic sorting technology (Stem Cell Technology). The cells were run on the FACSCanto flow cytometer after staining for CD38, CD45, CD56, activation markers CD71, CD69, CD154, adhesion markers CD49d, CD49e, CD11a, CD11b, and CD66, B cell markers CD19 and CD20, and for clonality.

RESULTS

There was a substantial loss in the expression of CD71, CD11b, CD11a, CD69, and CD49e on plasma cells following CD138-based sorting. Moreover, in 8 of the 16 cases, there was a nearly complete loss of the CD45-positive subset with a loss of discrimination between CD45-negative and CD45-positive plasma cell subsets in the remaining CD138-sorted preparations.

CONCLUSIONS

The change in immunophenotype of the plasma cells on magnetic sorting should be kept in mind when isolating plasma cells using CD138-positive selection for analysis of plasma cells. The technique for characterizing plasma cells should be selected based on the study design to prevent loss of crucial and valuable information.

摘要

背景

从单克隆丙种球蛋白病患者的骨髓中分离恶性浆细胞对于研究疾病生物学至关重要。浆细胞通常通过使用浆细胞标志物(如 CD138)进行阳性选择来分离。在这里,我们研究了 CD138 磁珠选择对浆细胞表面其他表型标志物表达的影响。

材料和方法

从 16 名患者的骨髓抽吸物中分离出两份样本,分别采用两种方法进行制备,然后进行流式细胞术评估染色。第一种方法(全骨髓)使用氯化铵-钾裂解全骨髓,然后用 2 次磷酸盐缓冲盐水洗涤。第二种方法使用 CD138 阳性磁分选技术(Stem Cell Technology)。细胞染色后在 FACSCanto 流式细胞仪上运行,用于 CD38、CD45、CD56、激活标志物 CD71、CD69、CD154、粘附标志物 CD49d、CD49e、CD11a、CD11b、CD66、B 细胞标志物 CD19 和 CD20 以及克隆性。

结果

基于 CD138 的分选后,浆细胞上的 CD71、CD11b、CD11a、CD69 和 CD49e 的表达大量丢失。此外,在 16 例病例中的 8 例中,几乎完全丢失了 CD45 阳性亚群,在剩余的 CD138 分选制备物中,CD45 阴性和 CD45 阳性浆细胞亚群之间的区分丧失。

结论

在用 CD138 阳性选择分离浆细胞进行浆细胞分析时,应牢记磁分选后浆细胞免疫表型的变化。应根据研究设计选择用于表征浆细胞的技术,以防止丢失关键和有价值的信息。

相似文献

1
Impact of CD138 Magnetic Bead-based Positive Selection on Bone Marrow Plasma Cell Surface Markers.基于 CD138 磁珠阳性选择对骨髓浆细胞表面标志物的影响。
Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e48-e51. doi: 10.1016/j.clml.2020.08.003. Epub 2020 Aug 5.
2
Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies.评估 CD229 作为单克隆丙种球蛋白血症流式免疫表型分析中浆细胞新的替代门控标记物。
Cytometry B Clin Cytom. 2018 May;94(3):509-519. doi: 10.1002/cyto.b.21619. Epub 2018 Jan 19.
3
Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.利用CD19、CD45、CD56、CD38和CD138对多发性骨髓瘤患者骨髓浆细胞进行流式细胞术评估及其与骨髓浸润率的相关性
Saudi Med J. 2004 Nov;25(11):1587-92.
4
Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells.用于多发性骨髓瘤的简化流式细胞术免疫表型分析组合,即CD56/CD19/CD138(CD38)/CD45,用于区分肿瘤性骨髓瘤细胞与反应性浆细胞。
Korean J Hematol. 2012 Dec;47(4):260-6. doi: 10.5045/kjh.2012.47.4.260. Epub 2012 Dec 24.
5
CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.CD19-CD45 低/-CD38 高/CD138+ 浆细胞富集人致瘤性骨髓瘤细胞。
Leukemia. 2012 Dec;26(12):2530-7. doi: 10.1038/leu.2012.140. Epub 2012 May 30.
6
C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.单克隆丙种球蛋白病中浆细胞上C-kit受体(CD117)的表达
Leuk Lymphoma. 2004 Nov;45(11):2281-9. doi: 10.1080/10428190412331283279.
7
The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.通过荧光分子信标在IgH基因重排的实时PCR中评估多发性骨髓瘤的微小残留病及其与流式细胞术的相关性。
J BUON. 2013 Apr-Jun;18(2):442-7.
8
Flow cytometric immunophenotypic characteristics of 36 cases of plasma cell leukemia.流式细胞术免疫表型特征 36 例浆细胞白血病。
Leuk Res. 2011 Feb;35(2):169-76. doi: 10.1016/j.leukres.2010.04.021.
9
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis.骨髓嗜酸性粒细胞生成的流式细胞免疫表型分化模式。
Cytometry B Clin Cytom. 2024 Sep;106(5):370-382. doi: 10.1002/cyto.b.22174. Epub 2024 Apr 26.
10
Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.306例多发性骨髓瘤的流式细胞术免疫表型分析
Am J Clin Pathol. 2004 Apr;121(4):482-8. doi: 10.1309/74R4-TB90-BUWH-27JX.

引用本文的文献

1
Diagnostic value of CD20 combined with CD138 positive expression in patients with chronic endometritis.CD20联合CD138阳性表达在慢性子宫内膜炎患者中的诊断价值
Am J Clin Exp Immunol. 2025 Jun 15;14(3):145-156. doi: 10.62347/LIHI3143. eCollection 2025.
2
Combined replacement of lnc-MEG3 and miR-155 elicit tumor suppression in multiple myeloma.lnc-MEG3和miR-155联合替代疗法可抑制多发性骨髓瘤。
Epigenomics. 2025 Feb;17(3):167-177. doi: 10.1080/17501911.2025.2453413. Epub 2025 Jan 16.
3
Investigating the effect of immunomagnetic separation on the immunophenotype and viability of plasma cells in plasma cell disorders.探讨免疫磁珠分离对浆细胞疾病中浆细胞免疫表型和活力的影响。
Pathol Oncol Res. 2024 Oct 18;30:1611882. doi: 10.3389/pore.2024.1611882. eCollection 2024.
4
Hypoxia-related prognostic model in bladder urothelial reflects immune cell infiltration.膀胱尿路上皮癌中缺氧相关的预后模型反映免疫细胞浸润。
Am J Cancer Res. 2021 Oct 15;11(10):5076-5093. eCollection 2021.

本文引用的文献

1
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016.多发性骨髓瘤全球负担:2016 年全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Sep 1;4(9):1221-1227. doi: 10.1001/jamaoncol.2018.2128.
4
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.国际骨髓瘤工作组多发性骨髓瘤反应和微小残留病评估的共识标准。
Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.
5
Immunophenotyping in multiple myeloma and related plasma cell disorders.多发性骨髓瘤及相关浆细胞疾病的免疫表型分析。
Best Pract Res Clin Haematol. 2010 Sep;23(3):433-51. doi: 10.1016/j.beha.2010.09.002.
6
Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.306例多发性骨髓瘤的流式细胞术免疫表型分析
Am J Clin Pathol. 2004 Apr;121(4):482-8. doi: 10.1309/74R4-TB90-BUWH-27JX.
7
Characterization of clonogenic multiple myeloma cells.克隆性多发性骨髓瘤细胞的特征分析
Blood. 2004 Mar 15;103(6):2332-6. doi: 10.1182/blood-2003-09-3064. Epub 2003 Nov 20.
8
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.单克隆丙种球蛋白病、多发性骨髓瘤及相关疾病的分类标准:国际骨髓瘤工作组报告
Br J Haematol. 2003 Jun;121(5):749-57.
9
The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells.骨髓瘤细胞抗原syndecan-1在凋亡的骨髓瘤细胞中丢失。
Br J Haematol. 1998 Mar;100(4):637-46. doi: 10.1046/j.1365-2141.1998.00623.x.
10
Isolation of bone marrow plasma cells by negative selection with immunomagnetic beads.
J Immunol Methods. 1996 Mar 28;190(1):127-31. doi: 10.1016/0022-1759(95)00269-3.